We are live on
!
Find out more
Tango Therapeutics
TNGX
TNGX
194 hedge funds and large institutions have $3.77B invested in Tango Therapeutics in 2026 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 64 increasing their positions, 56 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
147% more capital invested
Capital invested by funds: $1.53B → $3.77B (+$2.24B)
100% more funds holding in top 10
Funds holding in top 10: 7 → 14 (+7)
84% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 32
14% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 56
14% more funds holding
Funds holding: 170 → 194 (+24)
13% more call options, than puts
Call options by funds: $2.12M | Put options by funds: $1.87M
1.68% less ownership
Funds ownership: 128.01% → 126.33% (-1.7%)
Holders
194
Holders Change
+24
Holders Change %
+14.12%
% of All Funds
2.39%
Holding in Top 10
14
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+100%
% of All Funds
0.17%
New
59
Increased
64
Reduced
56
Closed
32
Calls
$2.12M
Puts
$1.87M
Net Calls
+$251K
Net Calls Change
-$324K
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$164M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$98M |
| 3 |
PBA
Paradigm Biocapital Advisors
New York
|
+$55.8M |
| 4 |
Holocene Advisors
New York
|
+$54.7M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$30.6M |
